Sadoff JC - Search Results

1

Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen.

Kotloff KL, Herrington DA, Hale TL, Newland JW, Van De Verg L, Cogan JP, Snoy PJ, Sadoff JC, Formal SB, Levine MM. Kotloff KL, et al. Among authors: sadoff jc. Infect Immun. 1992 Jun;60(6):2218-24. doi: 10.1128/iai.60.6.2218-2224.1992. Infect Immun. 1992. PMID: 1587589 Free PMC article. Clinical Trial.

2

Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.

Kotloff KL, Losonsky GA, Nataro JP, Wasserman SS, Hale TL, Taylor DN, Newland JW, Sadoff JC, Formal SB, Levine MM. Kotloff KL, et al. Among authors: sadoff jc. Vaccine. 1995 Apr;13(5):495-502. doi: 10.1016/0264-410x(94)00011-b. Vaccine. 1995. PMID: 7639017 Clinical Trial.

3

A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity.

Kotloff KL, Nataro JP, Losonsky GA, Wasserman SS, Hale TL, Taylor DN, Sadoff JC, Levine MM. Kotloff KL, et al. Among authors: sadoff jc. Vaccine. 1995 Nov;13(16):1488-94. doi: 10.1016/0264-410x(95)00102-7. Vaccine. 1995. PMID: 8578831 Clinical Trial.

4

Outpatient studies of the safety and immunogenicity of an auxotrophic Escherichia coli K-12-Shigella flexneri 2a hybrid vaccine candidate, EcSf2a-2.

Taylor DN, Phillip DF, Zapor M, Trofa A, Van de Verg L, Hartman A, Bendiuk N, Newland JW, Formal SB, Sadoff JC, et al. Taylor DN, et al. Among authors: sadoff jc. Vaccine. 1994 May;12(6):565-8. doi: 10.1016/0264-410x(94)90318-2. Vaccine. 1994. PMID: 8036831 Clinical Trial.

5

Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A.

Fries LF, Gordon DM, Schneider I, Beier JC, Long GW, Gross M, Que JU, Cryz SJ, Sadoff JC. Fries LF, et al. Among authors: sadoff jc. Infect Immun. 1992 May;60(5):1834-9. doi: 10.1128/iai.60.5.1834-1839.1992. Infect Immun. 1992. PMID: 1563771 Free PMC article.

6

Unusual lipopolysaccharide antigens of a Salmonella typhi oral vaccine strain expressing the Shigella sonnei form I antigen.

Seid RC Jr, Kopecko DJ, Sadoff JC, Schneider H, Baron LS, Formal SB. Seid RC Jr, et al. Among authors: sadoff jc. J Biol Chem. 1984 Jul 25;259(14):9028-34. J Biol Chem. 1984. PMID: 6378905 Free article.

7

Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines.

Szu SC, Taylor DN, Trofa AC, Clements JD, Shiloach J, Sadoff JC, Bryla DA, Robbins JB. Szu SC, et al. Among authors: sadoff jc. Infect Immun. 1994 Oct;62(10):4440-4. doi: 10.1128/iai.62.10.4440-4444.1994. Infect Immun. 1994. PMID: 7927707 Free PMC article.

8

Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults.

Cohen D, Ashkenazi S, Green MS, Gdalevich M, Robin G, Slepon R, Yavzori M, Orr N, Block C, Ashkenazi I, Shemer J, Taylor DN, Hale TL, Sadoff JC, Pavliakova D, Schneerson R, Robbins JB. Cohen D, et al. Among authors: sadoff jc. Lancet. 1997 Jan 18;349(9046):155-9. doi: 10.1016/S0140-6736(96)06255-1. Lancet. 1997. PMID: 9111538 Clinical Trial.

9

Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers.

Cohen D, Ashkenazi S, Green M, Lerman Y, Slepon R, Robin G, Orr N, Taylor DN, Sadoff JC, Chu C, Shiloach J, Schneerson R, Robbins JB. Cohen D, et al. Among authors: sadoff jc. Infect Immun. 1996 Oct;64(10):4074-7. doi: 10.1128/iai.64.10.4074-4077.1996. Infect Immun. 1996. PMID: 8926071 Free PMC article. Clinical Trial.

10

Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.

Taylor DN, Trofa AC, Sadoff J, Chu C, Bryla D, Shiloach J, Cohen D, Ashkenazi S, Lerman Y, Egan W, et al. Taylor DN, et al. Infect Immun. 1993 Sep;61(9):3678-87. doi: 10.1128/iai.61.9.3678-3687.1993. Infect Immun. 1993. PMID: 8359890 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters